For the third year in a row, the hundreds of millions of dollars poured into commercials for AbbVie’s immunology blockbusters have earned the Big Pharma the top spot on the year’s list of the top TV drug ad spenders. More:
read moreIncyte CEO Hervé Hoppenot took investors on a whirlwind tour of 18 events that could take place throughout 2025 during his recent presentation at the J.P. Morgan Healthcare Conference. More: JPM25: Incyte plans to turn 'a lot of cards' in
read more
Europe’s first biomarker trial seeks to prevent Crohn’s Disease onset More: Innovative Health Initiative launches a trial aimed at ending Crohn’s Disease Source: News
read more
NICE endorses Imfinzi and Tagrisso for enhanced lung cancer care More: AstraZeneca receives positive recommendations for lung cancer treatments Source: News
read moreFosun International’s proposed buyout of its partially owned subsidiary, Shanghai Henlius Biotech, has been quashed, with the necessary threshold of Henlius’ shareholders not voting in favor of the deal. More: Fosun's proposed Henlius Biotech buyout fails to pass shareholder vote
read moreAs Stelara biosimilars chip away at sales in Europe and off-brand rivals start to grace the stage in the U.S., Johnson & Johnson is confident it can eke out revenue growth this year. More: J&J stands by sales growth ambitions—and
read more© 1994 - 2026 B.M. Pharmaceuticals